Form 8-K - Current report:
SEC Accession No. 0000950170-23-013101
Filing Date
2023-04-17
Accepted
2023-04-17 17:01:27
Documents
12
Period of Report
2023-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230415.htm   iXBRL 8-K 52760
  Complete submission text file 0000950170-23-013101.txt   172816

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230415.xsd EX-101.SCH 2460
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230415_pre.xml EX-101.PRE 10225
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230415_lab.xml EX-101.LAB 13904
6 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230415_htm.xml XML 4881
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

EIN.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 23824614
SIC: 2834 Pharmaceutical Preparations